Faes FarmaHAM:FFEA 88 Market Cap is €1,419.4 Mil as of Jul. 07, 2026. GuruFocus rates HAM:FFEA with a GF Score™ of 88/100 and a GF Value™ of €5.21. The stock has 7 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Faes Farma ranks better than 81.54% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Faes Farma's share price for the quarter that ended in Dec. 2025 was €5.12. Faes Farma's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 311.3 Mil. Therefore, Faes Farma's market cap for the quarter that ended in Dec. 2025 was €1,593.7 Mil.
Faes Farma's quarterly market cap
stayed the same
from Dec. 2024 (€0.0 Mil) to Jun. 2025 (€0.0 Mil) but then
increased
from Jun. 2025 (€0.0 Mil) to Dec. 2025 (€1,593.7 Mil).
Faes Farma's annual market cap
stayed the same
from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then
increased
from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€1,593.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Faes Farma's Enterprise Value for Today is €1,715.6 Mil.
Faes Farma (HAM:FFEA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Faes Farma Market Cap Related Terms
Faes Farma Market Cap Historical Data
* Premium members only.
The historical data trend for Faes Farma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:FFEA vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Market Cap distribution charts can be found below:
* The bar in red indicates where Faes Farma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Faes Farma's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma (HAM:FFEA) has a Market Cap of €1,419.4 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Faes Farma and its competitors. According to the industry distribution chart, Faes Farma ranks #189 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 18.5%.
Is Faes Farma's Market Cap too high?
Faes Farma's current Market Cap is €1,419.4 Mil. Based on the distribution chart, Faes Farma ranks #189 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Faes Farma has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #189 out of 1024 companies for Market Cap. This places Faes Farma in the top 19% of its industry — outperforming the majority of peers. The industry median Market Cap is 220.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 220.02, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Faes Farma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 220.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current Market Cap is €1,419.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Faes Farma (HAM:FFEA) has a current Market Cap of €1,419.4 Mil. The stock's GF Value™ is €5.21, compared to a current price of €4.55 — trading 12.8% below its estimated fair value. The current Market Cap is €1,419.4 Mil. Faes Farma's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Faes Farma (HAM:FFEA), the current Market Cap is €1,419.4 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (HAM:FFEA) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.55 is trading 12.8% below its estimated GF Value™ of €5.21.
Key valuation signals for HAM:FFEA:
Market Cap: €1,419.4 Mil
GF Value™: €5.21 vs. price of €4.55 (12.8% below fair value)
No single metric tells the full story. See the HAM:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
88GF Score
Get the complete analysis for HAM:FFEA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:FFEA has been successfully added to your 
